WASHINGTON, March 29 (Reuters) - U.S. health officials withdrew the Parkinson’s disease drug pergolide from the market on Thursday, citing a history of safety concerns that include potentially fatal heart valve damage.
WASHINGTON, March 29 (Reuters) - U.S. health officials withdrew the Parkinson’s disease drug pergolide from the market on Thursday, citing a history of safety concerns that include potentially fatal heart valve damage.
